samedan logo

 
 
spacer
home > pmps > spring 2009 > confidence in compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Confidence in Compliance

Patient adherence to medicinal therapy is the prerequisite of any successful treatment. Furthermore, it is the prerequisite for an economical and efficient way of curing illnesses, or improving the general level of human health. Despite this, compliance is not the rule, but the exception. Non-compliance is an issue for individuals whose condition may worsen, or who may even die if they fail to take medication correctly. It is, however, just as much a concern for the public, as non-compliance leads to losses in productivity and increased expenses for modern medication, for better and more efficient drugs. The subsequent cost of non-compliance is not only that of the wasted medicines, but also the cost of emergency and acute intervention when medication is not taken.

The US National Council on Patient Information and Education (NCPIE) states: “Perhaps it is no surprise that one of the most common examples of patients not following their prescription regimen involves antibiotic therapy, usually when they stop taking their medicine prematurely. This can cause a recurrence of the condition that the antibiotics were originally prescribed to treat” (1). What is even more problematic in this instance is that non-compliance can cause the bacteria to become resistant to the initially applied antibiotics.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.

spacer
Starting his career as an international Sales Manager, Tassilo Korab has been in the packaging industry for more than 20 years. A recognised expert in flexible packaging, he holds an MSc in Healthcare Economics, and has written several publications on patient compliance, standards and regulations for child resistant packaging and the war against counterfeits. Tassilo is currently Managing Director of TKM Handels GmbH, Vienna, a consulting company in the sector of flexible packaging for the pharmaceutical and healthcare industries. He was one of the co-founders of HCPC-Europe, the Healthcare Compliance Packaging Council, a not-for-profit organisation uniting the pharmaceutical industry, packaging materials suppliers, packaging machine manufacturers and patient organisations in their common endeavour to improve drug packaging design in the interest of the patients. He has been Executive Director since September 2005.
spacer
Tassilo Korab
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables and Leachables testing services at its US Technology Excellence Center

Piombino Dese, Padua Italy and Salt Lake City, USA September 2, 2020: Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider of lab testing and expert advisory services signed today a partnership agreement that will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston, MA.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

A Magic Triangle: Practical insights into lactose-based DPI formulations

30 June 2021, Online webinar

Three leading companies with complementary areas of expertise have joined forces to conduct a unique multidisciplinary study into lactose-based DPI formulations including magnesium stearate. Their findings will give generic players a head start in the development process so that they can tap into this rapidly growing market. Lactose specialist DFE Pharma, powder processing technology manufacturer Hosokawa Micron and machine-building expert Harro Hoefliger will be presenting the key insights from their research to interested parties during a joint webinar on the 30th of June.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement